Two firms on the acquisition of Laboratório Canonne by Eurofarma
Stocche Forbes represented Eurofarma on the acquisition of Laboratório Canonne -(wich was represented by Mello Torres Advogados)-, a company that holds all assets, rights and obligations associated with the production and distribution of “Valda”, “Fixaderme”, “Practivar”, “Inove Calcio” and “Paravision” products.
The deal also involved the assignment of the brands related to the referred products by Gemar Gestão de Investimentos Financeiros, Marcas e Patentes to Eurofarma.
According to a document the Brazilian Securities and Exchange Commission (CVM), the pharmaceutical company disbursed around R$ 725 million in the acquisition.
Eurofarma operates in 20 countries in Latin America and is one of the largest companies of the national capital sector. It is the leader in prescriptions and second in generic drugs in Brazil.
Stocche Forbes advised Eurofarma Laboratórios and relied on partners Daniel Loria, Rafael Andrade and Flavio Meyer (in the first line from left to right); associates Pietro Bianchi, Luis Filipe Costa and Ana Caroline Moura; Amanda Melilo; Roberta Rodrigues and Mateus Lino; Paloma Cordeiro and Vitoria Coelho; Ana Paula Paschoalini, Vitor Jardim and Luisa Marcelino Bono and intern Luisa Tovar.
In-house counsel to Eurofarma Laboratórios: Lizandra Karen de Lima and Renan Bruno Agustini de Oliveira.
In-house counsel to Laboratório LC 001: Ithala Bianca Morais Suassuna Guimarães.
Mello Torres Advogados advised Laboratório Canonne and relied on partners Natália Teixeira Rabaça, Carlos José Rolim de Mello, Fabrício Cardim and Bruno Sartori (pictured second line from left to right); associates Mayara Ogea, Daniel Azevedo Nocetti and Pedro Henrique Matias Paes Barreto.
